Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
02/14/2007 | CN1300143C Temozolomide refining process |
02/14/2007 | CN1300142C Sulfonamide compounds and their production method and use |
02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
02/13/2007 | US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
02/13/2007 | US7176312 Kinase inhibitor scaffolds and methods for their preparation |
02/13/2007 | US7176311 Process for preparing pharmaceutically active compounds |
02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
02/13/2007 | US7176210 Cannabinoid receptor ligands and uses thereof |
02/13/2007 | US7176209 Fungicidal formulation |
02/13/2007 | US7176203 Imidazo-triazine derivatives as ligands for gaba receptors |
02/13/2007 | US7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
02/13/2007 | US7176194 Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds, and their use |
02/13/2007 | US7175958 Electrophotographic photoconductor, process for forming an image, image forming apparatus and process cartridge for the same |
02/13/2007 | CA2275191C Phosphorescent dendritic macromolecular compounds for imaging tissue oxygen |
02/08/2007 | WO2007016361A2 Novel pharmaceutical compounds |
02/08/2007 | WO2007016155A2 Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders |
02/08/2007 | WO2007015866A2 Inhibitors of p38 kinase and methods of treating inflammatory disorders |
02/08/2007 | WO2007015805A1 1-amino linked compounds |
02/08/2007 | WO2007015414A1 OXADIAZOLE-SUBSTITUTED Sym-TRIINDOLE DERIVATIVE AND ORGANIC EL ELEMENT EMPLOYING THE SAME |
02/08/2007 | WO2007015280A1 Benzodiazepine derivatives and uses thereof in medical field |
02/08/2007 | WO2007014926A1 Macrocyclic inhibitors of hepatitis c virus |
02/08/2007 | WO2007014925A1 Macrocylic inhibitors of hepatitis c virus |
02/08/2007 | WO2007014920A1 Macrocyclic inhibitors of hepatitis c virus |
02/08/2007 | WO2007014919A1 Macrocylic inhibitors of hepatitis c virus |
02/08/2007 | WO2006135796A3 Crystalline forms of a pyrrolotriazine compound |
02/08/2007 | WO2005103054A3 Bridged piperazine and piperidine derivatives as ccri antagonists |
02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
02/08/2007 | US20070032652 contacting a picolinic acid derivative with a benzothiazole derivative or tautomers thereof, in the presence of a non-nucleophilic base; compounds inhibit cell proliferation, induce cell apoptosis and stabilize a quadruplex structure |
02/08/2007 | US20070032651 Process for the preparation of carbostyril derivatives, such as aripiprazole and its intermediates |
02/08/2007 | US20070032640 Cytokine receptor |
02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
02/08/2007 | US20070032526 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
02/08/2007 | US20070032525 e.g. (1H-benzoimidazol-2-yl)-[1-(3,4-dichloro-benzyl)-piperidin-4-ylmethyl]-amine; chemokine (C-C motif) receptor antagonist; antiallergen; asthma and allergic rhinitis, atopic dermatitis, urticaria, contact dermatitis, alleriric coniunctivitis, inflammatory bowel disease, AIDS, eosinqphilia |
02/08/2007 | US20070032511 Amorphous ziprasidone mesylate |
02/08/2007 | US20070032495 Pyrazolotriazines as kinase inhibitors |
02/08/2007 | US20070032481 4-(4-fluoro-phenyl)-2-isopropyl-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidine; treatment or prevention of disease states mediated by 5-HT7 and/or 5-HT2 receptor |
02/08/2007 | US20070032473 Substituted amides and their use as medicaments |
02/08/2007 | US20070032469 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
02/08/2007 | US20070032418 Small-molecule inhibitors of angiogenin and rnases and in vivo and in vitro methods of using same |
02/08/2007 | US20070028807 Heat-stable diketopyrrolopyrrole pigment mixtures |
02/08/2007 | CA2617095A1 Macrocylic inhibitors of hepatitis c virus |
02/07/2007 | EP1749009A1 Method for producing a solution of pure triethylenediamine (teda) |
02/07/2007 | EP1749008A1 Bicyclic heterocycles as hiv integrase inhibitors |
02/07/2007 | EP1749007A2 Macrocyclic compounds as inhibitors of viral replication |
02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
02/07/2007 | EP1678182B1 Process for preparing substituted 5-amino-pyrazolo- [4,3-e]-1,2,4-triazolo [1,5-c]pyrimidines |
02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
02/07/2007 | EP1392693B1 Triazolopyrimidines fungicides |
02/07/2007 | EP1228070B1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
02/07/2007 | CN1910192A Metal complexes having vitamin B12 as a ligand |
02/07/2007 | CN1910188A Use of phthalocyanines as marking substances for liquids |
02/07/2007 | CN1910187A Triaza-cyclopenta [cd] indene derivatives |
02/07/2007 | CN1910186A 6-(2-chloro-5-halophenyl)-triazolopyrimidine, method for production and use thereof for controlling fungal pests and agents comprising the same |
02/07/2007 | CN1910185A Pyrrolopyrimidine and pyrrolotriazine derivatives as CRF receptor antagon |
02/07/2007 | CN1910164A Organic compounds |
02/07/2007 | CN1909908A Pyrazolo[1,5-a]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases |
02/07/2007 | CN1298721C Method of separating, large scale preparing porphyrin from complex reaction system |
02/07/2007 | CN1298720C Sinomenine derivative with C cycle connected to penetabasic heterocycle and synthesizing method |
02/07/2007 | CN1298716C 1-[(indol-3-yl)carbonyl] piperazine derivatives and their medical compositions |
02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
02/07/2007 | CN1298704C Isatine derivatives with neurotrophic activity |
02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
02/06/2007 | US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts |
02/06/2007 | US7173130 Detection of transmembrane potentials by optical methods |
02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
02/06/2007 | US7173039 Compounds that modulate or inhibit enzymes for occular diseases |
02/06/2007 | US7173035 Arylsulfonamide compounds |
02/06/2007 | US7173033 Nitrogen-containing heterocyclic compound |
02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
02/06/2007 | US7173031 Pyrrolotriazine kinase inhibitors |
02/06/2007 | US7173029 Fused heteroaryl derivatives |
02/06/2007 | US7173028 Pyrimidine derivatives |
02/06/2007 | US7173026 Pyrrolo [2,1-c][1,4]benzodiazepine-anthraquinone conjugates useful as antitumour agents |
02/06/2007 | US7173023 Novel benzazepine derivatives as enzyme inhibitors of monoamine oxidase for disease treatment |
02/06/2007 | US7173022 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides |
02/06/2007 | US7173021 Anticancer agents, prodrugs for treatment on skins and basification |
02/06/2007 | CA2411961C Novel process for the preparation of pyrazolopyrimidinones |
02/01/2007 | WO2007014214A2 Introverted cucurbituril compounds |
02/01/2007 | WO2007013964A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
02/01/2007 | WO2007013691A1 Spiro-cyclic compound |
02/01/2007 | WO2007013673A1 Fused heterocycles as lck inhibitors |
02/01/2007 | WO2007012953A2 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis |
02/01/2007 | WO2007012642A1 7-amino-6-thiadiazolyl- and -oxadiazolyl- 1, 2, 4-triazolo [1, 5 -a] pyrimidine compounds and use thereof for the prevention of fungal pests |
02/01/2007 | WO2007012603A1 Fungicide 6-phenyl-triazolopyrimidinyl amines |
02/01/2007 | WO2007012602A1 Fungicide 5-methyl-6-phenyl-triazolopyrimidinyl amines |
02/01/2007 | WO2007012601A1 6-phenyl-pyrazolopyrimidine-7-ylamine fungicides |
02/01/2007 | WO2007012600A1 Fungicidal 5-alkyl-6-phenylpyrazolopyrimidin-7-ylamines |
02/01/2007 | WO2007012599A1 Fungicidal 5-methyl-6-phenylpyrazolopyrimidin-7-ylamines |
02/01/2007 | WO2007012464A1 Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
02/01/2007 | WO2006086609A3 Inhibitors of tryptase |
02/01/2007 | WO2006064205A3 Process for the preparation of a boron-substituted porphyrin |
02/01/2007 | WO2005112919A3 Self-immolative linkers and drug conjugates |
02/01/2007 | US20070027317 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
02/01/2007 | US20070027312 Methods and intermediates for the synthesis of porphyrins |
02/01/2007 | US20070027311 Methods and intermediates for the synthesis of porphyrins |
02/01/2007 | US20070027171 Cycloalkanepyrrolopyridines as dp receptor antagonists |
02/01/2007 | US20070027166 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
02/01/2007 | US20070027156 Crf antagonists and heterobicyclic compounds |